Joanne Wuensch
Stock Analyst at Citigroup
(4.33)
# 348
Out of 5,154 analysts
453
Total ratings
63.85%
Success rate
11.05%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Neutral | $9.1 → $6.5 | $3.71 | +75.20% | 15 | Mar 6, 2026 | |
| COO The Cooper Companies | Maintains: Neutral | $88 → $87 | $76.55 | +13.65% | 23 | Mar 6, 2026 | |
| ITGR Integer Holdings | Maintains: Neutral | $75 → $92 | $84.03 | +9.48% | 10 | Feb 20, 2026 | |
| BLCO Bausch + Lomb | Maintains: Buy | $20 → $21 | $17.06 | +23.09% | 7 | Feb 19, 2026 | |
| PODD Insulet | Maintains: Buy | $380 → $345 | $237.01 | +45.56% | 17 | Feb 19, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintains: Neutral | $94 → $98 | $94.11 | +4.13% | 24 | Feb 11, 2026 | |
| HAE Haemonetics | Maintains: Neutral | $88 → $75 | $64.13 | +16.95% | 11 | Feb 6, 2026 | |
| BSX Boston Scientific | Maintains: Buy | $130 → $102 | $71.35 | +42.96% | 36 | Feb 5, 2026 | |
| ISRG Intuitive Surgical | Maintains: Neutral | $635 → $590 | $490.16 | +20.37% | 19 | Jan 23, 2026 | |
| ABT Abbott Laboratories | Maintains: Buy | $155 → $140 | $109.56 | +27.78% | 23 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $232 → $250 | $240.40 | +3.99% | 17 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $350 → $374 | $338.64 | +10.44% | 27 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $455 → $420 | $364.56 | +15.21% | 15 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $113 → $125 | $107.73 | +16.03% | 23 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $83 → $88 | $74.27 | +18.49% | 8 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $62 → $75 | $70.41 | +6.52% | 8 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $96 → $101 | $81.64 | +23.71% | 22 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $22 | $21.14 | +4.07% | 21 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $75 → $77 | $68.10 | +13.07% | 17 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $12 → $11 | $9.73 | +13.05% | 16 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $26 → $21 | $17.69 | +18.71% | 22 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $205 → $242 | $123.59 | +95.81% | 22 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $112 | $90.90 | +23.21% | 22 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6.5 → $4.15 | $2.02 | +105.45% | 12 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $220 → $250 | $167.12 | +49.59% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $69 | $81.33 | -15.16% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $109 → $127 | $252.87 | -49.78% | 6 | Dec 10, 2018 |
Sight Sciences
Mar 6, 2026
Maintains: Neutral
Price Target: $9.1 → $6.5
Current: $3.71
Upside: +75.20%
The Cooper Companies
Mar 6, 2026
Maintains: Neutral
Price Target: $88 → $87
Current: $76.55
Upside: +13.65%
Integer Holdings
Feb 20, 2026
Maintains: Neutral
Price Target: $75 → $92
Current: $84.03
Upside: +9.48%
Bausch + Lomb
Feb 19, 2026
Maintains: Buy
Price Target: $20 → $21
Current: $17.06
Upside: +23.09%
Insulet
Feb 19, 2026
Maintains: Buy
Price Target: $380 → $345
Current: $237.01
Upside: +45.56%
Zimmer Biomet Holdings
Feb 11, 2026
Maintains: Neutral
Price Target: $94 → $98
Current: $94.11
Upside: +4.13%
Haemonetics
Feb 6, 2026
Maintains: Neutral
Price Target: $88 → $75
Current: $64.13
Upside: +16.95%
Boston Scientific
Feb 5, 2026
Maintains: Buy
Price Target: $130 → $102
Current: $71.35
Upside: +42.96%
Intuitive Surgical
Jan 23, 2026
Maintains: Neutral
Price Target: $635 → $590
Current: $490.16
Upside: +20.37%
Abbott Laboratories
Jan 23, 2026
Maintains: Buy
Price Target: $155 → $140
Current: $109.56
Upside: +27.78%
Jan 22, 2026
Maintains: Buy
Price Target: $232 → $250
Current: $240.40
Upside: +3.99%
Jan 16, 2026
Downgrades: Neutral
Price Target: $350 → $374
Current: $338.64
Upside: +10.44%
Dec 11, 2025
Maintains: Buy
Price Target: $455 → $420
Current: $364.56
Upside: +15.21%
Dec 11, 2025
Maintains: Buy
Price Target: $113 → $125
Current: $107.73
Upside: +16.03%
Dec 11, 2025
Maintains: Neutral
Price Target: $83 → $88
Current: $74.27
Upside: +18.49%
Dec 11, 2025
Maintains: Neutral
Price Target: $62 → $75
Current: $70.41
Upside: +6.52%
Dec 11, 2025
Maintains: Buy
Price Target: $96 → $101
Current: $81.64
Upside: +23.71%
Dec 11, 2025
Maintains: Neutral
Price Target: $16 → $22
Current: $21.14
Upside: +4.07%
Dec 11, 2025
Maintains: Buy
Price Target: $75 → $77
Current: $68.10
Upside: +13.07%
Oct 31, 2025
Maintains: Sell
Price Target: $12 → $11
Current: $9.73
Upside: +13.05%
Oct 31, 2025
Maintains: Neutral
Price Target: $26 → $21
Current: $17.69
Upside: +18.71%
Oct 31, 2025
Maintains: Buy
Price Target: $205 → $242
Current: $123.59
Upside: +95.81%
Oct 7, 2025
Maintains: Buy
Price Target: $101 → $112
Current: $90.90
Upside: +23.21%
May 22, 2025
Maintains: Neutral
Price Target: $6.5 → $4.15
Current: $2.02
Upside: +105.45%
Dec 12, 2022
Upgrades: Neutral
Price Target: $220 → $250
Current: $167.12
Upside: +49.59%
Nov 17, 2022
Maintains: Neutral
Price Target: $67 → $69
Current: $81.33
Upside: -15.16%
Dec 10, 2018
Upgrades: Outperform
Price Target: $109 → $127
Current: $252.87
Upside: -49.78%